The size of the Europe Peripheral Intravenous Catheters Market was around USD 1.18 billion in 2020. It is expected to grow at a CAGR of 5.6% to reach USD 1.55 billion by 2025. It captures 27% of the global market.
Y-O-Y growth in the incidence of chronic diseases, innovations in the new medical treatments, and healthcare expenditure in the European countries are majorly accelerating the peripheral intravenous catheters market in this region. The rising elder people population is accelerating the demand of the market. The rise in chronic diseases like cancer, stroke, diabetes, upgraded healthcare system, and favorable reimbursement structures mount the PIVC market growth in this region. A growing number of surgery cases, availability of upgraded catheters, and increasing awareness among the people population are expected to surge the PIVC market growth during the analysis period.
The cost associated with the peripheral intravenous catheters is so expensive, which is unaffordable by some small hospitals is restricting the market. Lack of trained and experienced professionals required to use these peripheral IV catheters is restraining the growth. Safety issues regarding the utilization of PIVC like different infections will obstruct the market.
The European Peripheral Intravenous Catheters Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
Europe was the second-largest in the global PIVC market. The escalating aging population, huge expenses on healthcare, and advanced technologies resulting in a high surgical procedure rate propel the PIVC market growth during the analysis period. The UK is governing the market with a surge in an unhealthy lifestyle; age-related factors add people prone to chronic diseases. Growth in parenteral drug approvals and a rise in biological drugs obtainable in injectable forms are fueling the growth. Germany followed after the UK is leading the market due to the growing large number of hospitals, which accounts for maximum revenue growth, thus growing skilled human resources. Mounting demand for integrated/closed peripheral intravenous catheters and growing assumption of safety small and short PIVC are accelerating the market. Rising consciousness about the minimum invasive surgeries integrated and utilizing upgraded materials like Teflon and polytetrafluoroethylene in the product is to foster the market growth during the analysis period.
Key players in the Europe PVIC market profiled in this report are Smith Medical, Terumo Corporation, C. R. Bard, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Tangent Medical, and Vygon Group.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Short PIVC
5.1.2.1 Ported Peripheral Intravenous Catheter
5.1.2.2 Non-ported Peripheral Intravenous Catheter
5.1.3 Integrated/Closed PIVC
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Integrated/Closed catheters
5.2.3 Peripheral insertion catheters
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Clinics
5.3.4 Ambulatory Surgery Centers (ASCs)
5.3.5 Home Use
5.3.6 Others
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
5.4 Technology
5.4.1 Conventional Peripheral Intravenous Catheter
5.4.2 Safety Peripheral Intravenous Catheter
5.3.3 Y-o-Y Growth Analysis, By Technology
5.3.4 Market Attractiveness Analysis, By Technology
5.3.5 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Terumo Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 B. Braun Melsungen AG
8.3 Smiths Medical
8.4 Becton
8.5 Dickenson and Co.
8.6 Teleflex Inc.
8.7 C.R. Bard Inc.
8.8 Tangent Medical Technologies
8.9 Vygon SA
8.10 Argon Medical Devices Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
